檢索結果 - Ron Epelbaum

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
    Natural products as potential cancer therapy enhancers: A preclinical update

    Natural products as potential cancer therapy enhancers: A preclinical update 由 Abed Agbarya, Nili Ruimi, Ron Epelbaum, Eran Ben‐Arye, Jamal Mahajna

    出版 2014
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Fertility after treatment for Hodgkin's disease

    Fertility after treatment for Hodgkin's disease 由 Zeev Blumenfeld, Eldad J. Dann, Irit Avivi, Ron Epelbaum, Jacob M. Rowe

    出版 2002
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas

    Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas 由 Nissim Haim, Ron Epelbaum, Menachem Ben-Shahar, David Yarnitsky, Waleed Simri, Eliezer Robinson

    出版 1994
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Endocrinology: Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy

    Endocrinology: Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy 由 Zeev Blumenfeld, I. Avivi, Shai Linn, Ron Epelbaum, Menachem Ben-Shahar, Nissim Haim

    出版 1996
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma

    Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma 由 Zeev Blumenfeld, Irith Avivi, Ari Eckman, Ron Epelbaum, Jacob M. Rowe, Eldad J. Dann

    出版 2007
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Tumor Aggressiveness and Patient Outcome in Cancer of the Pancreas Assessed by Dynamic <sup>18</sup>F-FDG PET/CT

    Tumor Aggressiveness and Patient Outcome in Cancer of the Pancreas Assessed by Dynamic <sup>18</sup>F-FDG PET/CT 由 Ron Epelbaum, Alex Frenkel, Riad Haddad, Natalia Sikorski, Ludwig G. Strauss, Ora Israel, Antonia Dimitrakopoulou‐Strauss

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma

    Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin ly... 由 Eldad J. Dann, Ron Epelbaum, Irit Avivi, Menachem Ben Shahar, Nissim Haim, Jacob M. Rowe, Zeev Blumenfeld

    出版 2005
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Docetaxel (TaxotereTM) is active in non-small-cell lung cancer: a phase II trial of the EORTC early clinical trials group (ECTG)

    Docetaxel (TaxotereTM) is active in non-small-cell lung cancer: a phase II trial of the EORTC early clinical trials group (ECTG) 由 Thomas Cerny, Steven Kaplan, N. Pavlidis, Patrick Schöffski, Ron Epelbaum, J Van Meerbeek, J. Wanders, H. R. Franklin, S.B. Kaye

    出版 1994
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Mutant <i>KRAS</i> Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring

    Mutant <i>KRAS</i> Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring 由 Ruth Perets, Orli Greenberg, Talia Shentzer, Valeria Semenisty, Ron Epelbaum, Tova Bick, Shada Sarji, Ofer Ben‐Izhak, Edmond Sabo, Dov Hershkovitz

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    <sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients

    <sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients 由 Michal Weiler‐Sagie, Olga Bushelev, Ron Epelbaum, Eldad J. Dann, Nissim Haim, Irit Avivi, Ayelet Ben‐Barak, Yehudit Ben-Arie, Rachel Bar‐Shalom, Ora Israel

    出版 2009
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Primary spinal epidural lymphoma: Patients’ profile, outcome, and prognostic factors: A multicenter Rare Cancer Network study

    Primary spinal epidural lymphoma: Patients’ profile, outcome, and prognostic factors: A multicenter Rare Cancer Network study 由 Virginie Monnard, A. Sun, Ron Epelbaum, Philip Poortmans, Robert C. Miller, Tom Verschueren, Luciano Scandolaro, S. Villà, Sabine Balmer Majno, Sandrine Ostermann, Mahmut Özsahin, René-Olivier Mirimanoff

    出版 2006
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome

    Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome 由 Eldad J. Dann, Rachel Bar‐Shalom, Ada Tamir, Nissim Haim, Menachem Ben‐Shachar, Irit Avivi, Tzila Zuckerman, Mark Kirschbaum, Odelia Goor, Diana Libster, Jacob M. Rowe, Ron Epelbaum

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious <i>BRCA</i> Mutation

    Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious <i>BRCA</i> Mutation 由 Rachna T. Shroff, Andrew Hendifar, Robert R. McWilliams, Ravit Geva, Ron Epelbaum, Lindsey Rolfe, Sandra Goble, Kevin Lin, Andrew V. Biankin, Heidi Giordano, Robert H. Vonderheide, Susan M. Domchek

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer

    Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer 由 Talia Golan, Tal Sella, Eileen M. O’Reilly, Matthew H. G. Katz, Ron Epelbaum, David P. Kelsen, Ayelet Borgida, Hannah Maynard, Hedy L. Kindler, Eitan Friedmen, Milind Javle, Steven Gallinger

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers

    Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers 由 Talia Golan, Zaheer Kanji, Ron Epelbaum, Nicholas Devaud, Efrat Dagan, Spring Holter, Dan Aderka, Shani Paluch‐Shimon, Brett A. Kaufman, Ruth Gershoni‐Baruch, David W. Hedley, Malcolm J. Moore, Eitan Friedman, Steven Gallinger

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Primary Mucosa-Associated Lymphoid Tissue Lymphoma of the Salivary Glands: A Multicenter Rare Cancer Network Study

    Primary Mucosa-Associated Lymphoid Tissue Lymphoma of the Salivary Glands: A Multicenter Rare Cancer Network Study 由 Yavuz Anacak, Robert C. Miller, Nikos Constantinou, A.M. Mamusa, Ron Epelbaum, Ye‐Xiong Li, Anna Lucas Calduch, Anna Kowalczyk, Damien C. Weber, Sidney P. Kadish, Nuran Beşe, P. Poortmans, Serra Kamer, Mahmut Özsahin

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Primary breast lymphoma: Patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study

    Primary breast lymphoma: Patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study 由 Wendy Jeanneret‐Sozzi, Alphonse G. Taghian, Ron Epelbaum, Philip Poortmans, Daniel R. Zwahlen, Beat Amsler, S. Villette, Yazid Belkacémi, Tan Dat Nguyen, Pierre Scalliet, P. Maingon, Cristina Gutiérrez, Pauline Gastelblum, Marco Krengli, Rita Abi Raad, Mahmut Özsahin, René‐Olivier Mirimanoff

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: